Three Healthcare Stocks Show Strong Revenue Performance
Eli Lilly, Intuitive Surgical, and Vertex Pharmaceuticals report significant revenue growth driven by weight loss drugs, robotic surgery systems, and cystic fibrosis treatments.
Topic
Latest reporting and analysis tagged with Revenue Growth.
Eli Lilly, Intuitive Surgical, and Vertex Pharmaceuticals report significant revenue growth driven by weight loss drugs, robotic surgery systems, and cystic fibrosis treatments.
Palantir Technologies' stock has risen sharply due to strong demand for its AI-driven software, with recent quarterly revenue growth exceeding double digits. However, investors express concerns over high valuations.
Figma Inc. reported strong Q3 2025 revenue growth, crossing a $1 billion annual run rate, while RBC Capital lowered its price target on the stock.